Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. [electronic resource]
Producer: 20200817Description: 792-798 p. digitalISSN:- 1096-8652
- Aged
- Antineoplastic Agents -- administration & dosage
- Female
- Fusariosis -- chemically induced
- Fusarium
- Humans
- Incidence
- Invasive Fungal Infections -- chemically induced
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Myelodysplastic Syndromes -- drug therapy
- Retrospective Studies
- Risk Factors
- Scedosporium
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.